<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page1_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page1_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>25</o:Revision>
  <o:TotalTime>345</o:TotalTime>
  <o:Created>2006-10-20T11:30:00Z</o:Created>
  <o:LastSaved>2006-11-02T13:00:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>881</o:Words>
  <o:Characters>5023</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>41</o:Lines>
  <o:Paragraphs>10</o:Paragraphs>
  <o:CharactersWithSpaces>6168</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	font-style:italic;}
h3
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:#FF9900;}
h6
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:36.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	color:white;
	font-weight:normal;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin:0cm;
	margin-bottom:.0001pt;
	text-indent:36.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1035"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:147.75pt;
 height:48pt'>
 <v:imagedata src="./Page1_files/image001.png" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=197 height=64
src="./Page1_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%" bgcolor="#003366"
 style='width:100.0%;background:#003366;border-collapse:collapse;mso-padding-alt:
 0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td valign=top style='padding:0cm 5.4pt 0cm 5.4pt'>
  <h6>Protein of the Month</h6>
  </td>
 </tr>
</table>

<p class=MsoNormal>November 2006</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width="33%" style='width:33.34%;border-top:solid #003366 .5pt;border-left:
  none;border-bottom:solid #003366 .5pt;border-right:none;background:#E0EFFF;
  mso-shading:windowtext;mso-pattern:horz-cross #BBDDFF;padding:0cm 5.4pt 0cm 5.4pt'>
  <h3><span style='color:#003366'>MORE ON THIS MONTH’S PROTEIN<o:p></o:p></span></h3>
  </td>
  <td width="15%" valign=top style='width:15.0%;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right'><![if !supportEmptyParas]>&nbsp;<![endif]><b><span
  style='color:#FF9900'><o:p></o:p></span></b></p>
  </td>
  <td width="33%" style='width:33.32%;border-top:solid #003366 .5pt;border-left:
  none;border-bottom:solid #003366 .5pt;border-right:none;background:#E0EFFF;
  mso-shading:windowtext;mso-pattern:horz-cross #BBDDFF;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  style='color:#003366'>OTHER PROTEINS OF INTEREST<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr>
  <td width="33%" valign=top style='width:33.34%;border:none;mso-border-top-alt:
  solid #003366 .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal><a
  href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb83_1.html"
  title="Link to the structural features of Fibrin"><span style='text-decoration:
  none;text-underline:none'><!--[if gte vml 1]><v:shape id="_x0000_i1026"
   type="#_x0000_t75" style='width:109.5pt;height:28.5pt'>
   <v:imagedata src="./Page1_files/image003.png" o:title="PDB_original"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=146 height=38
  src="./Page1_files/image004.gif" v:shapes="_x0000_i1026"><![endif]></span></a></p>
  <p class=MsoNormal><a
  href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb83_1.html"
  title="Link to the structural features of Fibrin">Molecule of the Month:
  Fibrin</a></p>
  <p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
  <td width="15%" valign=top style='width:15.0%;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
  <td width="33%" valign=top style='width:33.32%;border:none;mso-border-top-alt:
  solid #003366 .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal align=right style='text-align:right'><a
  href="http://www.expasy.org/spotlight/"
  title="ExPASy Protein Spotlight Article"><span style='text-decoration:none;
  text-underline:none'><!--[if gte vml 1]><v:shape id="_x0000_i1027" type="#_x0000_t75"
   style='width:168pt;height:28.5pt'>
   <v:imagedata src="./Page1_files/image005.jpg" o:title="Expasy_protein_spotlight"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=224 height=38
  src="./Page1_files/image006.jpg" v:shapes="_x0000_i1027"><![endif]></span></a></p>
  <p class=MsoNormal align=right style='text-align:right'><a
  href="http://www.expasy.org/spotlight/" title="ExPASy Protein Spotlight">ExPASy
  Protein Spotlight</a></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'><span style='font-size:36.0pt;
mso-bidi-font-size:16.0pt;color:maroon'>Fibrinogen<o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-size:14.0pt;
mso-bidi-font-size:16.0pt;font-family:"Times New Roman";font-weight:normal'>By <a
href="mailto:jennifer@ebi.ac.uk?subject=Protein%20of%20the%20Month"
title="Contact the author">Jennifer McDowall</a><o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Blood
clotting, or coagulation, is a rapid response to tissue damage, where the
exposure of <a href="http://www.ebi.ac.uk/interpro/potm/2006_3/Page1.htm"
title="Protein of the Month: Tissue Factor">tissue factor</a> containing cells
to the bloodstream through damage to vessel walls initiates a rapid cascade
system.<span style="mso-spacerun: yes">  </span>This enzyme cascade uses a series
of enzymes to work in rapid succession to amplify a small response into a large
one at the site of damage (see Figure 1).<span style="mso-spacerun: yes"> 
</span>Once activated, tissue factor (TF) binds and activates factor VII
(FVII), initiating the cascade.<span style="mso-spacerun: yes">  </span>TF/FVII
is activated through auto-cleavage to TF/FVIIa, which along with cofactor
FVIIIa converts FIX to FIXa; FXa can then convert FX to FXa, which along with
cofactor FVa converts FII (prothrombin) to FIIa (thrombin); finally FIIa
converts fibrinogen to fibrin, leading to fibrin deposition and the activation
of platelets to form blood clots.<span style="mso-spacerun: yes">  </span>The
activation of FXIII to FXIIIa can stabilise these blood clots by cross-linking
them.</p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#CCCCCC;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoBodyText align=center style='text-align:center'><!--[if gte vml 1]><v:shape
   id="_x0000_i1028" type="#_x0000_t75" style='width:453.75pt;height:105.75pt'>
   <v:imagedata src="./Page1_files/image007.png" o:title="Blood_coagulation"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=605 height=141
  src="./Page1_files/image008.jpg" v:shapes="_x0000_i1028"><![endif]></p>
  <p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#FFA7A7;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><u>Figure 1</u>.<b><span
  style="mso-spacerun: yes">  </span>Blood Coagulation Cascade</b></p>
  </td>
 </tr>
</table>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='font-size:14.0pt;mso-bidi-font-size:16.0pt;color:maroon'>Fibrinogen,
Finishing the Coagulation Cascade<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyTextIndent style='text-align:justify'>Fibrinogen was first
isolated from horse plasma by Hammarsten in 1876, although an inactive
precursor to fibrin was proposed to exist as early as 1859 by Deni de
Commercy.<span style="mso-spacerun: yes">  </span>Fibrinogen can undergo a
remarkable transformation from soluble monomers (fibrogen) to an insoluble polymer
gel (polymerised fibrin).</p>

<p class=MsoBodyTextIndent style='text-align:justify'>Fibrinogen is a plasma
glycoprotein synthesised in the liver that is essential for haemostasis
(stopping blood loss from damaged tissues), wound healing, fibrinolysis,
inflammation, angiogenesis, cellular and matrix interactions, and
neoplasia.<span style="mso-spacerun: yes">  </span>These processes involve the
conversion of fibrinogen to fibrin, and often the interaction of fibrin(ogen)
to various proteins and cells.<span style="mso-spacerun: yes">  </span>People
usually carry about 2.5g fibrinogen/L of blood, however, concentrations of
fibrogen can increase by as much as 200-400% during times of physiological
stress (primarily due to the actions of macrophage-derived interleukin-6).<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>Fibrinogen is
a large, complex glycoprotein composed of three pairs of polypeptides: two A<span
style='font-family:Symbol'>a</span>, two B<span style='font-family:Symbol'>b</span>,
and two <span style='font-family:Symbol'>g</span>.<span style="mso-spacerun:
yes">  </span>These polypeptides are linked together by 29 disulphide bonds,
some of which are depicted in Figure 2 below.<span style="mso-spacerun: yes"> 
</span>The polypeptides are oriented so all six N-terminal ends meet to form
the central E domain.<span style="mso-spacerun: yes">  </span>Two regions of
coiled coil alpha helices stretch out on either side of the E domain, each
consisting of one A<span style='font-family:Symbol'>a</span>, one B<span
style='font-family:Symbol'>b</span> and one <span style='font-family:Symbol'>g</span>
polypeptide.<span style="mso-spacerun: yes">  </span>Each coiled coil region
ends in a globular D domain consisting of the C-terminal ends of B<span
style='font-family:Symbol'>b</span> and <span style='font-family:Symbol'>g</span>,
as well as part of A<span style='font-family:Symbol'>a</span>.<span
style="mso-spacerun: yes">  </span>The C-terminal end of A<span
style='font-family:Symbol'>a</span> then protrudes from each D domain as a long
strand; these A<span style='font-family:Symbol'>a</span> protuberances can
interact with each other and with the E domain during fibrin clot
cross-linking.<span style="mso-spacerun: yes">  </span>Both the E and D domains
contain important binding sites for the conversion of fibrinogen to fibrin, for
fibrin assembly and cross-linking, and for platelet aggregation. <span
style="mso-spacerun: yes"> </span>Bound calcium ions are important to help
maintain the structure of fibrinogen.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>The N-terminal
ends of both the A<span style='font-family:Symbol'>a</span> and B<span
style='font-family:Symbol'>b</span> polypeptides are cleaved by thrombin in
order to turn soluble fibrinogen into gel-forming fibrin.<span
style="mso-spacerun: yes">  </span>Once cleaved from fibrinogen, the N-terminal
ends are known as fibrinopeptide A (from A<span style='font-family:Symbol'>a</span>
polypeptide) and fibrinopeptide B (from B<span style='font-family:Symbol'>b</span>
polypeptide).</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=635 valign=top style='width:476.1pt;background:#CCCCCC;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoBodyText align=center style='text-align:center'><!--[if gte vml 1]><v:shape
   id="_x0000_i1031" type="#_x0000_t75" style='width:453.75pt;height:229.5pt'>
   <v:imagedata src="./Page1_files/image009.png" o:title="Fibringoen_structure4"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=605 height=306
  src="./Page1_files/image010.jpg" v:shapes="_x0000_i1031"><![endif]></p>
  <p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=635 valign=top style='width:476.1pt;background:#FFA7A7;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><u>Figure 2</u>.<b><span
  style="mso-spacerun: yes">  </span>Fibrinogen:<o:p></o:p></b></p>
  <p class=MsoBodyText align=center style='text-align:center'>TOP – polypeptide
  organisation of fibrinogen.</p>
  <p class=MsoBodyText align=center style='text-align:center'>BOTTOM - domain
  organisation of fibrinogen.</p>
  </td>
 </tr>
</table>

<h1><span style='font-size:14.0pt;mso-bidi-font-size:16.0pt;color:maroon'>Blood
Clot Formation<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>In order to
form a blood clot, fibrinogen must first be cleaved by thrombin to remove the
fibrinopeptides.<span style="mso-spacerun: yes">  </span>The removal of
fibrinopeptides A and B from the N-terminal ends of A<span style='font-family:
Symbol'>a</span> and B<span style='font-family:Symbol'>b</span> exposes ‘knobs’
on the E domain, which can interact with the ‘holes’ always present on the D
domains.<span style="mso-spacerun: yes">  </span>Fibrin molecules can link
together through the interaction of the E domain on one fibrin molecule to the
D domains on four other fibrin molecules, thereby polymerising to form
staggered oligomers that build up into protofibrils.<span style="mso-spacerun:
yes">  </span>As the fibrin oligomers aggregate, these protofibrils continue to
lengthen to make long fibres that can wind around one another to make multi-stranded,
thick bundles, and which can branch into a 3-dimentional network of entangled
fibres, the fibrin clot.<span style="mso-spacerun: yes">  </span>The fibrin
clot is then stabilised by Factor XIIIa, a transglutaminase, where the zymogen
form of Factor XIII is converted to active Factor XIIIa through the action of
thrombin (see Figure 1).<span style="mso-spacerun: yes">  </span>Factor XIIIa
cross-links glutamine residues on one fibrin molecule to the lysine residues on
another fibrin molecule by forming strong isopeptide bonds.<span
style="mso-spacerun: yes">  </span>This cross-linking occurs between the
C-terminal ends (A<span style='font-family:Symbol'>a</span> protuberances) of
the A<span style='font-family:Symbol'>a</span> polypeptides, as well as (more
slowly) at other sites, such as between the C-terminal ends of <span
style='font-family:Symbol'>g</span> chains.<span style="mso-spacerun: yes"> 
</span>These cross-links help strengthen the fibrin clot, making it more
resistant to physical and chemical damage.</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#CCCCCC;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoBodyText align=center style='text-align:center'><!--[if gte vml 1]><v:shape
   id="_x0000_i1030" type="#_x0000_t75" style='width:453.75pt;height:364.5pt'>
   <v:imagedata src="./Page1_files/image011.png" o:title="Fibrin_assembly3"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=605 height=486
  src="./Page1_files/image012.jpg" v:shapes="_x0000_i1030"><![endif]></p>
  <p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#FFA7A7;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><u>Figure 3</u>.<b><span
  style="mso-spacerun: yes">  </span>Fibrin Polymerisation and lysis:</b><span
  style="mso-spacerun: yes">  </span>Pathway of fibrin polymerisation and
  breakdown.<span style="mso-spacerun: yes">  </span>The knobs on the E domain
  bind to the holes on up to four D domains (grey lines), forming a long,
  fibrous latticework.<span style="mso-spacerun: yes">  </span>The clot is then
  stabilised through cross-linking.<span style="mso-spacerun: yes">  </span>The
  clot can be degraded, yielding different degradation products if it has been
  cross-linked.</p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 align=center style='text-align:center'><span style='font-size:16.0pt;
mso-bidi-font-size:14.0pt;font-style:normal'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page2.htm" title="Page 2">Wound Healing</a><o:p></o:p></span></h2>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
